| Primary |
| Hormone Replacement Therapy |
92.4% |
| Menopausal Symptoms |
1.8% |
| Menopause |
1.2% |
| Hot Flush |
0.6% |
| Hypertension |
0.4% |
| Hypothyroidism |
0.4% |
| Hormone Therapy |
0.3% |
| Hysterectomy |
0.3% |
| Osteoporosis |
0.3% |
| Product Used For Unknown Indication |
0.3% |
| Spinal Anaesthesia |
0.3% |
| Diabetes Mellitus |
0.2% |
| Blood Cholesterol Increased |
0.2% |
| Anxiety |
0.2% |
| Burkitt's Lymphoma |
0.2% |
| Mood Swings |
0.2% |
| Blood Pressure Increased |
0.2% |
| Ill-defined Disorder |
0.1% |
| Night Sweats |
0.1% |
| Gastrooesophageal Reflux Disease |
0.1% |
|
| Breast Cancer Female |
76.9% |
| Application Site Erythema |
4.1% |
| Application Site Pruritus |
2.7% |
| Application Site Rash |
2.6% |
| Breast Cancer |
2.3% |
| Pharmaceutical Product Complaint |
1.5% |
| Application Site Irritation |
1.4% |
| Hot Flush |
1.1% |
| Application Site Vesicles |
1.0% |
| Product Substitution Issue |
0.9% |
| Drug Ineffective |
0.8% |
| Application Site Burn |
0.7% |
| Application Site Pain |
0.7% |
| Application Site Reaction |
0.5% |
| Headache |
0.5% |
| Pruritus |
0.5% |
| Pulmonary Embolism |
0.5% |
| Coeliac Disease |
0.4% |
| Hypersensitivity |
0.4% |
| Pain |
0.4% |
|
| Secondary |
| Hormone Replacement Therapy |
70.2% |
| Menopausal Symptoms |
9.2% |
| Menopause |
5.4% |
| Drug Use For Unknown Indication |
2.0% |
| Hypertension |
1.4% |
| Depression |
1.2% |
| Hot Flush |
1.2% |
| Product Used For Unknown Indication |
1.1% |
| Anxiety |
1.0% |
| Oestrogen Replacement Therapy |
0.8% |
| Hormone Therapy |
0.8% |
| Migraine |
0.8% |
| Dyspepsia |
0.7% |
| Mood Swings |
0.6% |
| Osteoporosis |
0.6% |
| Asthma |
0.6% |
| Blood Cholesterol Increased |
0.5% |
| Bronchitis |
0.5% |
| Emotional Disorder |
0.5% |
| Pain |
0.5% |
|
| Breast Cancer |
41.4% |
| Breast Cancer Female |
31.9% |
| Breast Cancer Metastatic |
8.2% |
| Ovarian Cancer |
3.8% |
| Invasive Ductal Breast Carcinoma |
1.7% |
| Progesterone Receptor Assay Positive |
1.5% |
| Breast Cancer In Situ |
1.3% |
| Cerebrovascular Accident |
1.2% |
| Breast Cancer Recurrent |
1.2% |
| Myoclonus |
0.9% |
| Weight Decreased |
0.9% |
| Hot Flush |
0.8% |
| Application Site Erythema |
0.7% |
| Drug Ineffective |
0.7% |
| Oestrogen Receptor Assay Positive |
0.7% |
| Swelling Face |
0.7% |
| Myalgia |
0.6% |
| Pulmonary Embolism |
0.6% |
| Vulvovaginal Dryness |
0.6% |
| Weight Increased |
0.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.6% |
| Drug Use For Unknown Indication |
11.0% |
| Rheumatoid Arthritis |
5.8% |
| Hormone Replacement Therapy |
5.5% |
| Hypertension |
5.5% |
| Depression |
5.2% |
| Pain |
5.0% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Anxiety |
2.8% |
| Crohn's Disease |
2.7% |
| Asthma |
2.6% |
| Osteoporosis |
2.6% |
| Hypothyroidism |
2.3% |
| Fibromyalgia |
2.3% |
| Multiple Sclerosis |
2.1% |
| Insomnia |
2.0% |
| Migraine |
2.0% |
| Blood Cholesterol Increased |
1.9% |
| Vitamin Supplementation |
1.7% |
| Smoking Cessation Therapy |
1.6% |
|
| Vomiting |
13.2% |
| Weight Increased |
11.4% |
| Weight Decreased |
9.4% |
| Nausea |
7.6% |
| Pain |
5.1% |
| Drug Ineffective |
4.5% |
| Injection Site Pain |
4.2% |
| Vision Blurred |
4.2% |
| Pruritus |
4.1% |
| Rash |
4.0% |
| Urticaria |
3.9% |
| Wrong Technique In Drug Usage Process |
3.9% |
| Somnolence |
3.7% |
| Urinary Tract Infection |
3.5% |
| Headache |
3.4% |
| Pyrexia |
3.0% |
| Pain In Extremity |
2.9% |
| Tremor |
2.9% |
| Insomnia |
2.6% |
| Product Quality Issue |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
26.7% |
| Anxiety |
13.3% |
| Musculoskeletal Chest Pain |
13.3% |
| Smoking Cessation Therapy |
10.0% |
| Bursitis |
6.7% |
| Cough |
6.7% |
| Wheezing |
6.7% |
| Hormone Therapy |
3.3% |
| Low Density Lipoprotein Increased |
3.3% |
| Migraine |
3.3% |
| Painful Respiration |
3.3% |
| Respiratory Disorder |
3.3% |
|
| Drug Interaction |
16.7% |
| Homicidal Ideation |
16.7% |
| Increased Tendency To Bruise |
16.7% |
| Musculoskeletal Chest Pain |
16.7% |
| Presyncope |
16.7% |
| Rash |
16.7% |
|
